Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Cusp Overlap for Higher CoreValve Implantation

Implant depth greater than the length of the membranous septum is an independent predictor of permanent pacemaker implantation. Valve implantation 3 to 5 mm below the aortic annulus in a projection coaxial to the device is recommended. The problem is this is rarely in the annular plane of the valve.

Cirugía para mejorar la sobrevida en insuficiencia tricuspidea aislada

Ideal annular plane projection is normally suggested by CT. For CoreValves, correction of parallax was achieved by adding right anterior oblique caudal angulation, which preserves the anatomic annular plane of the native valve and produces an overlap of right and left coronary cusps (cusp overlap).

This differs from manufacturer recommendation to use left anterior oblique angulation. This produces a shallower apparent device depth of 1 to 2 mm.

This technique could enable higher implantation, making the self-expandable valve more competitive in terms of conduction, vs balloon expandable valves. 

The risk of excessively higher implantation with this technique might increase paravalvular regurgitation, or even embolization.  


Read also: Should Total Occlusion Influence on Revascularization Strategy?


Small observational studies on cusp overlap have shown permanent pacemaker implantation rate lower than 5% for CoreValve and no significant increase in leak or device embolization. 

Implantation 3 to 5 mm below the aortic annulus, using a radiographic projection chosen for both the valve and the device can help improve permanent pacemaker implantation rate. 

This should be confirmed by multicenter registries, with special attention to low-risk population. 

CIRCINTERVENTIONS-120-009258free

Original Title Low Rates of Permanent Pacing Are Observed Following Self-Expanding Transcatheter Aortic Valve Replacement Using an Annular Plane Projection for Deployment.

Reference: Anthony D. Pisaniello et al. Circ Cardiovasc Interv. 2021;14:e009258. DOI: 10.1161/CIRCINTERVENTIONS.120.009258.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...